Stabilization of cellular membranes as a target of vascular therapy

Kardiologiya

Volumn 51, Issue 4, 2011, Pages 52-55

  Inzhutova, A I ^a   Larionov, A A ^a   Petrova, M M ^a   Salmina, A B ^a  

^a NONE

Author keywords

Cellular membranes; External cytoplasmatic membrane blebbing; Trimetazidine

Indexed keywords

TRIMETAZIDINE; VASODILATOR AGENT;

ADULT; ARTICLE; BIOLOGICAL MODEL; CELL MEMBRANE; CELL PROTECTION; COMPARATIVE EFFECTIVENESS; DRUG EFFECT; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; LYMPHOCYTE; MALE; MEMBRANE MICROPARTICLE; METABOLISM; MIDDLE AGED; PATHOLOGY; PATHOPHYSIOLOGY; PHASE CONTRAST MICROSCOPY; TREATMENT OUTCOME; ULTRASTRUCTURE; VASCULAR ENDOTHELIUM;

ADULT; CELL MEMBRANE; CELL-DERIVED MICROPARTICLES; COMPARATIVE EFFECTIVENESS RESEARCH; CYTOPROTECTION; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; LYMPHOCYTES; MALE; MICROSCOPY, PHASE-CONTRAST; MIDDLE AGED; MODELS, CARDIOVASCULAR; MYOCARDIAL ISCHEMIA; TREATMENT OUTCOME; TRIMETAZIDINE; VASODILATOR AGENTS;

EID: 79960938758     PISSN: 00229040     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Heilzer T., Schlinzig T., Krohn K. Endothelial Dysfunction, Oxidative Stress, and Risk of Cardiovascular Events in Patients With Coronary Artery Disease. Circulation 2001;104:2673-2678.
2. Benameur T., Andriantsitohaima R., Carmen Martínez M. Therapeutic potential of plasma membrane-derived microparticles. Pharmacol Report 2009;1:49-57.
3. Morel O., Toti F., Morel, N. Microparticles in endothelial cell and vascular homeostasis: are they really noxious? Hematology 2009;3:313-317.